Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Flexion Therapeutics Inc (FLXN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]85.673.022.50.40.00.00.00.0
            Revenue growth  17.3%223.9%6244.8%     
Cost of goods sold  19.210.07.30.00.00.00.00.0
Gross profit  66.363.015.20.40.00.00.00.0
            Gross margin  77.5%86.3%67.4%98.9%    
Selling, general and administrative   [+]105.0129.7121.378.828.513.49.16.7
Research and development  54.369.653.151.241.332.717.911.1
EBITDA   [+]-91.3-135.2-157.5-127.7-68.6-45.8-26.9-17.7
            EBITDA margin  -106.7%-185.3%-699.2%-35964.2%    
Depreciation and amortization  1.71.11.72.01.20.20.10.1
EBIT   [+]-93.0-136.3-159.2-129.7-69.8-46.1-27.0-17.8
            EBIT margin  -108.7%-186.8%-706.8%-36529.9%    
Interest expense, net   [+]19.213.911.17.60.2-0.7-0.10.2
Other income (expense), net   [+]-1.00.40.7-0.2-1.9-0.9-0.4-0.2
Pre-tax income  -113.2-149.8-169.7-137.5-71.9-46.3-27.3-18.2
Income taxes  0.50.00.00.00.00.00.00.0
            Tax rate   0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -113.7-149.8-169.7-137.5-71.9-46.3-27.3-18.2
            Net margin  -132.9%-205.3%-753.2%-38727.0%    
   
Basic EPS   [+]($2.53)($3.93)($4.49)($4.16)($2.84)($2.15)($1.97)($23.02)
Diluted EPS   [+]($2.53)($3.93)($4.49)($4.16)($2.84)($2.15)($1.97)($23.02)
   
Shares outstanding (basic)   [+]45.038.137.833.025.321.513.90.8
Shares outstanding (diluted)   [+]45.038.137.833.025.321.513.90.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy